Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma

•Low-dose doxorubicin or dopamine can be used as an immunomodulator to eliminate MDSC.•MDSC elimination is closely related to regulate the STAT pathways in MDSC.•MDSC elimination can delay TAM polarization, inhibit Tregs and proliferate T cells.•STAT1 pathway was activated while STAT3, STAT5 and STA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunology letters 2021-12, Vol.240, p.31-40
Hauptverfasser: Xu, Weili, Li, Suolin, Li, Meng, Yang, Xiaofeng, Xie, Shaojian, Lin, Lin, Li, Guixin, Zhou, Hui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Low-dose doxorubicin or dopamine can be used as an immunomodulator to eliminate MDSC.•MDSC elimination is closely related to regulate the STAT pathways in MDSC.•MDSC elimination can delay TAM polarization, inhibit Tregs and proliferate T cells.•STAT1 pathway was activated while STAT3, STAT5 and STAT6 pathways were inactivated.•MDSC elimination alleviate immunosuppression and improve efficacy of neuroblastoma. Neuroblastoma (NB) has high morality rates and is the most common malignant tumor found in children. High aggregation of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment results in immunosuppression and affects therapeutic effectiveness. At present, doxorubicin (DOX) and dopamine (DA) are the specific drugs used to selectively remove or mature MDSCs. The aim of the present study was to explore the feasibility and underlying mechanism of targeting elimination of MDSCs via DOX or DA administration to alleviate tumor immunosuppression in NB. In the present study, a BALB/c tumor-bearing mouse model was established, and mice were grouped into the control, DOX2.5, DOX5 and DA50 mg/kg groups. DOX or DA were injected intravenously on days 7 and 12 after inoculation, following which the parameters related to the signal transducer and activator of transcription (STAT) pathway in MDSCs, the proportion of MDSCs, T cell infiltration, programmed death-1 (PD-1) on the surface of T cells, the number of regulatory T cells (Tregs), polarization of tumor-related macrophages (TAMs) and tumor growth were compared between the groups on days 14, 17 and 23 after inoculation. The results demonstrated that following DOX or DA administration, STAT1/phosphorylated (p)-STAT1 decreased, whereas STAT3/p-STAT3, STAT5/p-STAT5 and STAT6/p-STAT6 increased, which was accompanied by a decrease in the MDSC proportion in each experimental group. Simultaneously, T cell infiltration in tumors was increased, whereas expression of PD-1, the number of Tregs, TAM polarization and tumor growth were inhibited. The most significant findings were observed in the DOX2.5 mg/kg group. To conclude, low dose DOX or DA administration could effectively regulate the STAT pathway to eliminate MDSCs, alleviate immunosuppression and improve the immune response against NB tumor cells.
ISSN:0165-2478
1879-0542
DOI:10.1016/j.imlet.2021.09.011